A single-center cohort study found no differences between males and females in the odds of starting or time to treatment in generalized myasthenia gravis (gMG), but investigators want to continue to probe more deeply into why women are more severely affected by the disease. ...
myasthenia gravisIntroduction Acetylcholine receptor antibody-positive generalized myasthenia gravis (gMG) is effectively treated with symptomatic and immunosuppressive drugs but a proportion of patients has a persistent disease and severe adverse events (AEs). The unmet medical needs are specific ...
This article presents a summary of the new medications approved for generalized myasthenia gravis (gMG) since 2017. Pivotal clinical trials that led to the
An expert neurologist discusses the use of targeted therapies to personalize treatment for patients with generalized myasthenia gravis (gMG) and reviews the impact on quality of life, the challenges of managing the disease, as well as new and emerging th
This type of MG generally has a good prognosis when symptoms are well controlled with treatment. Generalized MG, also known as gMG, is characterized by widespread muscle weakness that, as its name suggests, is not restricted to a particular muscle group. The most common type of MG, it also...
Can living with myasthenia gravis have benefits? Frequency of URTIs higher when MG is treated with rituximab Living with MG can feel isolating at times, but we’re not alone FDA grants nipocalimab priority review for the treatment of gMG FAQs...
Management of myasthenia gravis The therapeutic strategy in MG is guided by the clinical pattern (ocular versus generalised), autoantibody subtype, and disease severity. Current therapy of MG revolves around symptomatic treatment (cholinesterase inhibitors), long term steroids and steroid-sparing immunomodul...
The US Food and Drug Administration (FDA) has approvedefgartigimod(Vyvgart, argenx), a first-in-class,targeted therapyfor adults with generalizedmyasthenia gravis(gMG) who test positive for the antiacetylcholine receptor (AChR) antibody.
Management of myasthenia gravis The therapeutic strategy in MG is guided by the clinical pattern (ocular versus generalised), autoantibody subtype, and disease severity. Current therapy of MG revolves around symptomatic treatment (cholinesterase inhibitors), long term steroids and steroid-sparing immunomodul...
5) Ocular myasthenia gravis 眼肌型重症肌无力 1. Thymectomy in treatment of ocular myasthenia gravis: A report of 17 cases; 胸腺切除术治疗眼肌型重症肌无力(附17例分析) 2. Objective To study and estimate the value of SFEMG of the frontalis muscle in the diagnosis of ocular myasthenia gravis...